Genital Diseases, Female  >>  seribantumab (MM-121)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
seribantumab (MM-121) / Elevation Oncology
NCT01209195: A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Checkmark Combination of MM121 and paclitaxel (ESMO 2012)
Sep 2012 - Oct 2012: Combination of MM121 and paclitaxel (ESMO 2012)
Checkmark P1 data- ESMO
Sep 2012 - Sep 2012: P1 data- ESMO
Completed
1
41
US
MM-121, Seribantumab, SAR256212, Paclitaxel, Taxol
Merrimack Pharmaceuticals, Sanofi
Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,, Primary Peritoneal Cancer or Endometrial Cancer, Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
05/14
07/14

Download Options